The Challenge
“Testing is critical to stopping the virus. Testing assists in knowing where the virus exists and if a person need to isolate himself. Having this knowledge prevents the virus from spreading.”
Coronavirus disease have existed long before the 2019 Coronavirus disease (COVID-19) , the latest coronavirus to impact the world. Coronaviruses can trigger respiratory infections. While some of these viruses will only trigger the common cold, others may produce more significant and potentially fatal diseases. These include severe acute respiratory syndrome or SARS, among others.
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It was first identified in December 2019 in Wuhan, China, and has since spread globally, resulting in an ongoing pandemic. Cases have been reported across 187 countries and territories, unfortunately resulting in thousands of deaths.
Common symptoms include fever, cough, fatigue, shortness of breath, and loss of smell and taste. While the majority of cases result in mild symptoms, some progress to acute respiratory distress syndrome (ARDS), multi-organ failure, septic shock, and blood clots. The time from exposure to onset of symptoms is typically around five days but may range from two to fourteen days.
Testing is critical to stopping the virus. Testing assists in knowing where the virus exists and if a person need to isolate himself. Having this knowledge prevents the virus from spreading. The WHO has published several testing protocols for the disease. The standard method of testing is real-time reverse transcription polymerase chain reaction (rRT-PCR). The test is typically done on respiratory samples obtained by a nasopharyngeal swab; however, a nasal swab or sputum sample may also be used. Results are generally available within a few hours to two days. Blood tests can be used, but these require two blood samples taken two weeks apart, and the results have little immediate value. Scientists were able to isolate a strain of the coronavirus and publish the genetic sequence so laboratories across the world could independently develop polymerase chain reaction (PCR) tests to detect infection by the virus. As of 4 April 2020, antibody tests (which may detect active infections and whether a person had been infected in the past) were in development, but not yet widely used.
But it has become difficult for testing efforts to take place throughout the world. Many testing sites are available in multiple countries, including drive-through testing services in some locales. The problem with many testing efforts is that they are often inaccurate and hard to control. What’s worse is that these testing points don’t have enough protection for the test operators and the potentially infected people who need testing. The long waiting lines at some testing sites and the inability of people to get access to those spots only makes matters worse.
The Solution
The Portuguese company PH9.5, Lda. has partnered with a Swiss manufacturer of Rapid Test to produce a new testing system, the CoV(i)Kiosk® Test System by PH9.5, Lda. The new unit can identify the virus as soon as possible in a setup design that is self-contained. It provides safety to lab workers and others by producing an environment for testing that is mobile, efficient, fast, and affordable to operate.
The new setup CoV(i)Kiosk® Test System by PH9.5. The CoV(i)Kiosk® have been designed in Portugal for use throughout the world.
The CoV(i)Kiosk® Test System by PH9.5 was developed to provide Rapid Test as secure approach to COVID-19 testing. The unit speeds up testing and reduces the cost of testing.
The CoV(i)Kiosk® Test System by PH9.5 lets a test operator gather samples without having to put on personal protective equipment. The worker will remain protected against the virus during the process. The design ensures the operator can handle the diagnostic work while also not having to waste PPE materials that may be unavailable or hard to access or conserve.
How the System Works
The CoV(i)Kiosk® Test System by PH9.5 system uses a unique design that entails a few steps:
- The lab-tester will utilize rubber gloves that are attached to a isolation panel in the CoV(i)Kiosk® Test System by PH9.5.
- The lab-tester will take an oral,nasal an/or blood sample from the patient and then move the sample to the proper space.
- The lab-tester will then disinfect the gloves after the test is complete, and the sample will be stored out of the way. A powerful disinfectant will be applied to the rub glove and the test counter. A new test can occur after the disinfection is complete.
- A UV-ozone germicidal light system kills off small particles that may appear on the inside of the CoV(i)Kiosk® Test System by PH9.5.
The setup ensures that testing can generate the diagnostic in as little time as possible.
Proper Separation
The CoV(i)Kiosk® Test System by PH9.5 uses a full barrier of separation between the lab-tester and the patient. In addition to glove protection, there is also a nanoparticle filter utilized in the system to keep the air the tester breathes clean and safe. The filter is similar to what works in labs that handle bio-hazardous materials.An air-conditioner unit is also a componet of the CoV(i)Kiosk® Test System by PH9.5. The unit is self-contained inside the Kiosk to prevent cross-contamination. The comfortable design allows the worker to operate without any PPE, outside of the rubber gloves. Also a anti-fatigue mat is in every unit to prevent the fatigue of the lab-tester legs.
A Balistic-Proof Acrylic pane exist between the lab worker and the patient. This partion protects both sides.
The separation ensures that the only form of contact made between the tester and the patient is through the lab-strength rubber gloves. Those gloves will always be disinfected in between patients to ensure protection for all parties. Also, there is no need to replace the PPE setup between patients. It becomes easier to test more people without having to replace items that break down in little time.
Optional Adaptation
Depending the region where the CoV(i)Kiosk® Test System by PH9.5 will be used adaptation can made such as adding Power Generator or Power Inverter may be included inbed to the CoV(i)Kiosk® Test System by PH9.5 if necessary. The generator or the inverter will be able assist in producing energy needed for operational purposes in isolated areas or area where there is no energy.
Simple to Transport
The CoV(i)Kiosk® Test System by PH9.5 is easy to set up in multiple areas. The body features a lightweight material that will maintain its shape and will not break fragment during transportation. Its physical dimension makes it easy to transport by air or land. A CoV(i)Kiosk® Test System by PH9.5 will fit through cargo-plane doors for Inter-Continental shipment without having to adjust anything. Dimensões para transporte 180cm x 250cm x 170cmm.
Lowered Cost
The general cost of testing will also decrease. Since there’s less of a need to replace things or to spend time between patients, it becomes easier to accurately and safely test more people without using extra PPEs material. People can go through the test system without long waiting, and the operator will not waste funds on unnecessary material.
Building Hope
The most important part of the new CoV(i)Kiosk® by PH9.5, Lda. is that it will bring a sense of hope to the world. COVID-19 has impacted most of the world, as millions have been infected and thousands have died, not to mention many societies have shut down, causing tremendous harm to the economy of most countries.
Proper testing is critical to containing the virus. The point comes as many people who have it do not show symptoms, thus being capable of spreading the potentially fatal virus to others. The ability to detect COVID-19 while also protecting the medical workers who collect samples is critical to stopping the virus.
The CoV(i)Kiosk® by PH9.5, Lda. ensures the testing process is safe and secure. It provides hope in the war against COVID-19, as being able to test rapidilly will brings relief to everyone.
The system can be personalize for your organization such as this personalization for the Instituto Projeto Neymar Jr.:
Os Kiosks estão disponíveis em configurações ideais para cada país aonde será usado.
Todas a vendas em Portugal acrescida de IVA/VAT de 23%, nas exportações não será cobrado IVA/VAT.
Images
Contact
PH9.5 Lda. (PT) Company and VAT No. 514 798 734
Location:
Rua Conde de Idanha-a-Nova,
240 RC Fundão, 6230-348 Portugal
Email:
info@covikiosk.com
Call:
+351 275 105 125
Whatsapp me:
+351 9695 15398
Our Partners And Suppliers
During the development of the the Cov(i)Kiosk several suppliers were instrumental in its implementation among them.
FundaBuilding, is dedicated to Construction of houses, buildings, sales of those acquired for the purpose, mechanical metalwork, construction and public work. They are based in Fundao, Portugal For their website Click Here
AluSistema, a is a manufactor of Aluminum and PVC Frames and Products such as:
- Sliding and opening windows in aluminum and PVC
- Aluminum Sliding Gates
- Aluminum Swing Gates
- Shutters
- Blinds / Blackouts
- Facades
- Partitions
They are based in Fundao, Portugal For their website Click Here
The FAB LAB Aldeias do Xisto operates in the old Municipal Square of Fundão and is a space for low-cost creation and experimentation, where there are no limits to creativity. This laboratory, whose main promoter is the Municipality of Fundão, was the first to be born in the region, betting on a strategy of innovation and entrepreneurship. Here, you will find advanced technology that is available to the citizen, helping him to find the most appropriate solutions to new creative and entrepreneurial paths. Although accessible to the community in general, it is especially aimed at the academic communities of higher education institutions For Details
To complete we have made a partnership with a Swiss company Spring Healthcare, focused on the development of rapid tests in several pathologies, but specially COVID-19. Their tests are done with Swiss quality and precision and are certified by the FDA, CE European Certification and duly communicated as required by laws to Inframed to be used in Portugal.
OUR DISTRIBUITORS ARE
Germanic Countries
Spain And France
North America, Brazil, Latin America And Carribean
Western Europe And The Isles
Asia/Oceania
Eastern Europe
North Africa
Central Africa
South Africa